A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CB1Rs / CB1 receptors

[Related PubMed/MEDLINE]
Total Number of Papers: 50
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CB1Rs  (>> Co-occurring Abbreviation)
Long Form:   CB1 receptors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal. SCRAs
2022 Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance. Ang II, AT1Rs, RAS
2022 Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research. Delta9-THC, ICSS
2021 Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions. ---
2021 Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses. ---
2021 Mechanisms of endocannabinoid control of synaptic plasticity. eCBs
2021 Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability. MORs, T2D
2020 Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids. CNS, eCBs
2020 Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: a pivotal role in stress-induced analgesia. i.c.v, i.pag, LH, mGlu5Rs, NK1Rs, NPS, NPSRs, OX1 Rs, SIA, vlPAG
10  2018 Astrocytic Mechanisms Involving Kynurenic Acid Control Delta9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. alpha7nAChRs, KYNA, mPFC, NAcS, THC, VTA
11  2018 Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats. BSR
12  2018 Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. CIBP, PrNMI
13  2017 A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. ECS, PEA, sIPSC
14  2017 CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Delta9-Tetrahydrocannabinol (Delta9-THC)-Induced Aversive Effects in Mice. Delta9-THC, ICSS, VGLUT2, VTA
15  2016 Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Delta9 -tetrahydrocannabinol. Delta9 -THC, LTP
16  2016 Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection. ACPA
17  2016 Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors. A2ARs, mGluR5, NMDARs
18  2015 Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation. CNS, CRIP1a, G-protein, HEK
19  2015 Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper. CBRs, eCBs, GABA, MT, SNpr
20  2015 Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists. AEA, cAMP, DR
21  2015 Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. A2ARs, WIN, WT
22  2014 Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm. TRPV1
23  2014 CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis. LTP, TBS
24  2014 Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors. FS, GABA, GABAARs, IPSCs
25  2014 Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. eCBs
26  2014 The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. 2-AG, DGLalpha, LTD, SAG, THL
27  2013 Activation of cannabinoid CB1 receptors modulates evoked action potentials in rat retinal ganglion cells. RGCs
28  2013 Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice. ADHD, D2Rs, LTD
29  2013 Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice. eCB system, HPA
30  2012 AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. MORs
31  2012 Brain regional differences in CB1 receptor adaptation and regulation of transcription. CREB, IEGs
32  2012 Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. IL-1beta, TRPV1
33  2011 Cannabinoid CB1 receptors regulate neuronal TNF-alpha effects in experimental autoimmune encephalomyelitis. EAE, EPSCs, FAAH, MS, TNF-alpha
34  2011 The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. D1Rs
35  2011 The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing. 2-AG, DAR, eCB, FAAH, MGL, mGluR5, NAc, PLC
36  2011 The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. 2-AG, MAGL
37  2011 Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease. HD, WIN
38  2011 Worsening of Huntington disease phenotype in CB1 receptor knockout mice. 3-NP, HD
39  2010 Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. A1Rs, eADO, SC
40  2010 Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. AEA, FAAH, HPA
41  2009 Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. i.c.v, MORs
42  2008 Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. EC, EPSCs, mEPSC
43  2008 Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors. mAChR, MAP, NAc, nAChRs, PrC
44  2007 Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. FST, mPFCv
45  2007 Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus. eCB, GABA, I-LTD, IPSPs, microORs
46  2005 Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. JAK2, LH, MAPK
47  2005 Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. NAc, THC
48  2004 A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. eCB, LTD, mGluR5s, NAc, NMDAR
49  2004 Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat. LRT, WIN
50  2003 Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. CNS, FST, i.p, KO, TST